Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club

23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...

Read more →

FDA approves Eylea (aflibercept) injection for diabetic retinopathy

13 May 2019 - Eylea improves diabetic retinopathy and prevents worsening disease that can lead to blindness. ...

Read more →

FDA approves broadened indication for Xeomin (incobotulinumtoxinA) as first-line treatment for blepharospasm (involuntary blinking) in adult patients

13 May 2019 - Merz Americas announced today that the U.S. FDA has approved the supplemental biologics license application for Xeomin ...

Read more →

Helping Canadians get faster access to the prescription drugs they need to live healthier lives

13 May 2019 - Government of Canada consults on new approach to fast-track the review of treatments for serious, rare ...

Read more →

Cellectar receives FDA fast track designation for CLR 131 in relapsed or refractory multiple myeloma

13 May 2019 - Designation could accelerate CLR 131 development and underscores the need for new treatments. ...

Read more →

Celgene Corporation announces Pomalyst granted breakthrough therapy designation from FDA for HIV positive and negative Kaposi sarcoma

13 May 2019 - Celgene plans to submit sNDA by end of 2019. ...

Read more →

Novartis pitches discounts on pricey gene therapy for deadly muscle disorder

11 May 2019 - Novartis is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal ...

Read more →

Japan health ministry orders Ono Pharmaceutical to add warning to Opdivo cancer drug after death

10 May 2019 - The health ministry said Thursday that a patient taking the cancer drug Opdivo has died and ...

Read more →

Congress should revive the Office of Technology Assessment

13 May 2019 - In recent decades, the U.S. economy and society have been propelled forward by a boom in science ...

Read more →

HTA frameworks for RA therapies need improvement, researchers say

13 May 2019 - Cost-effectiveness models for the treatment of rheumatoid arthritis first emerged in the early 2000s when highly effective ...

Read more →

Australia's GBMA launches hub for biosimilar education

13 May 2019 - In 2018, the Generic Biosimilar Medicines Association was awarded the Biosimilar Education Grant by the Australian government ...

Read more →

New cancer drugs approved for NHS use in Scotland

13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...

Read more →

House Budget Committee announces hearing on single payer health care

10 May 2019 - The House Budget Committee on Friday announced that it will hold a hearing on single-payer health ...

Read more →

SMC - May 2019 decisions

13 May 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Considerations in demonstrating interchangeability with a reference product guidance for industry

9 May 2019 - This guidance is intended to assist sponsors in demonstrating that a proposed therapeutic protein product is interchangeable ...

Read more →

Safety, efficacy, and quality remain top priorities as we continue our work to expand access to cost-saving generic drugs for the American public

13 May 2019 - Millions of Americans have difficulty paying for their prescription medications. ...

Read more →